Nevertheless, a specific cut-points could be found to discriminate patients into high-risk and low-risk groups significantly having different overall survival time and CNAs of ErbB family were still potentially biomarkers of prognosis in lung cancer. This evidence concerns the gene EGFR and lung carcinoma.